Cabozantinib trials for Lung cancer

All Cabozantinib trials · All Lung cancer trials

Phase breakdown

Recruiting trials studying Cabozantinib for Lung cancer

• A Pilot Phase II Study of Maintenance Cabozantinib Plus Pembrolizumab for Patients With Metastatic Squamous Non-Small Cell Lung Cancer (sqNSCLC)
  NCT05613413 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
  NCT01639508 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
  NCT06026410 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 38 locations

Common questions

How many trials study Cabozantinib for Lung cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.